截短型CSF3受体在严重先天性中性粒细胞减少症中诱导促炎反应
研究将患者来源的CSF3R截短突变引入ELANE-SCN和HAX1-SCN来源及对照诱导多能干细胞,比较其造血祖细胞的CSF3反应。结果显示SCN患者的CSF3R突变型造血祖细胞增殖不增加,但炎症信号升高,提示截短型CSF3R激活在SCN中不引起克隆性生长而是持续促炎状态。
要点
- SCN患者的CSF3R突变型造血祖细胞未见增殖增加,但炎症信号水平升高。
- 与对照CSF3R突变型造血祖细胞不同,SCN来源的突变型造血祖细胞不表现增殖优势。
- 截短型CSF3R在SCN造血祖细胞中激活引起持续促炎状态,而非克隆性扩增。
核心结论
- 在SCN患者的造血祖细胞中激活截短型CSF3R不引起克隆性生长,而是导致持续促炎状态,这对理解这些CSF3R突变如何促进SCN的白血病转化具有意义。
研究设计与样本
- 研究将患者来源的CSF3R截短突变引入ELANE-SCN和HAX1-SCN来源及对照诱导多能干细胞,并比较这些细胞系产生的造血祖细胞的CSF3反应。
主要发现
- 与CSF3R突变型对照造血祖细胞相比,SCN患者的CSF3R突变型造血祖细胞不显示增殖增加,但炎症信号水平升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe congenital neutropenia (SCN) patients are prone to develop myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML). Leukaemic progression of SCN is associated with the early acquisition of CSF3R mutations in haematopoietic progenitor cells (HPCs), which truncate the colony-stimulating factor 3 receptor (CSF3R). These mutant clones may arise years before MDS/AML becomes overt. Introduction and activation of CSF3R truncation mutants in normal HPCs causes a clonally dominant myeloproliferative state in mice treated with CSF3. Paradoxically, in SCN patients receiving CSF3 therapy, clonal dominance of CSF3R mutant clones usually occurs only after the acquisition of additional mutations shortly before frank MDS or AML is diagnosed. To seek an explanation for this discrepancy, we introduced a patient-derived CSF3R-truncating mutation in ELANE-SCN and HAX1-SCN derived and control induced pluripotent stem cells and compared the CSF3 responses of HPCs generated from these lines. In contrast to CSF3R-mutant control HPCs, CSF3R-mutant HPCs from SCN patients do not show increased proliferation but display elevated levels of inflammatory signalling. Thus, activation of the truncated CSF3R in SCN-HPCs does not evoke clonal outgrowth but causes a sustained pro-inflammatory state, which has ramifications for how these CSF3R mutants contribute to the leukaemic transformation of SCN.
引用
- Olofsen PA, Bosch DA, de Looper HWJ, et al. Truncated CSF3 receptors induce pro-inflammatory responses in severe congenital neutropenia. Br J Haematol. 2022. PMID: 36168923. doi:10.1111/bjh.18477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。